Biotech BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease June 13, 2025
Biotech Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine June 13, 2025
Biotech Enliven Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants June 13, 2025
Biotech Fapon Biopharma to Showcase Differentiated Pipeline, Including Phase 1 Immunocytokine FP008, and Innovative Technology Platforms at BIO 2025 June 12, 2025
Biotech Dizal Showcases Two First-in-Class Therapies in Hematologic Malignancies at EHA and ICML 2025 June 12, 2025
Biotech Ascend Completes GMP Certification for Quality Control Testing in Munich Facility June 11, 2025
Biotech Energenesis Biomedical to Unveil Promising Parkinson’s Disease Therapy, ENERGI-F705PD, at BIO International 2025 June 11, 2025
Biotech Caliway to Present First Preclinical Data on CBL-514 for GLP-1 Weight Rebound Management at BIO 2025 June 10, 2025
Biotech BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team June 10, 2025